Novel Hemostatic Bio-Plate Derived from Honey Jelly Bee Extract

From recent research in biomolecular wound-healing materials, a new generation bioactive hemostatic plate can be conceptualized using a modified honey-jelly bee extract matrix fabricated into a square hydrogel plate designed for rapid hemorrhage control. The plate is placed directly on an actively bleeding human wound, where its bioactive compounds interact with clotting pathways and tissue regeneration mechanisms. The formulation integrates concentrated bee-derived biomolecules known for antimicrobial, anti-inflammatory, and coagulation-supporting properties. A proposed laboratory composition may include: royal jelly extract (35–40%), medical-grade honey enzymatic fraction (25–30%), bee propolis flavonoid complex (10–15%), chitosan biopolymer scaffold (10–12%), and calcium alginate clot-activation matrix (5–8%), with trace peptides and antimicrobial enzymes (~1–3%). Upon application, the plate rapidly absorbs blood while activating platelet aggregation and fibrin formation, potentially reducing severe bleeding within 30–90 seconds depending on wound depth. The honey-enzyme system (glucose oxidase → hydrogen peroxide micro-release) simultaneously provides localized antimicrobial protection, while royal jelly peptides and flavonoids reduce inflammation and accelerate tissue repair. Preliminary modeling suggests that such a bio-plate could shorten hemorrhage stabilization time by 40–60% compared with standard gauze compression, while providing rapid analgesic relief through anti-inflammatory bioactive compounds. This design represents a potential next-generation bio-derived emergency wound dressing combining natural bee biochemistry with modern biomaterial engineering.